Publications

Sonpavde, Guru, Thomas E. Hutson, Matthew D. Galsky, and William R. Berry. “Problems with the randomized discontinuation design..” J Clin Oncol 24, no. 28 (October 1, 2006): 4669–70. https://doi.org/10.1200/JCO.2006.08.1026.

PMID
17008711
Full Text

Anscher, Mitchell S., Jennifer Garst, Lawrence B. Marks, Nicole Larrier, Frank Dunphy, James E. Herndon, Robert Clough, et al. “Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury..” Int J Radiat Oncol Biol Phys 66, no. 2 (October 1, 2006): 477–82. https://doi.org/10.1016/j.ijrobp.2006.05.031.

PMID
16904841
Full Text

Dinan, Michaela A., Kevin P. Weinfurt, Joëlle Y. Friedman, Jennifer S. Allsbrook, Julie Gottlieb, Kevin A. Schulman, Mark A. Hall, Jatinder K. Dhillon, and Jeremy Sugarman. “Comparison of conflict of interest policies and reported practices in academic medical centers in the United States..” Account Res 13, no. 4 (October 2006): 325–42. https://doi.org/10.1080/08989620601003414.

PMID
17849643
Full Text

Brigidi, Bart D., Renee H. Raynor, and Henry S. Friedman. “Neurocognitive deficits according to hemisphere and diagnosis among patients with high-grade CNS tumors.” In Neuro Oncology, 8:476–77. DUKE UNIV PRESS, 2006.

Scholars@Duke

Brigidi, Bart D., Renee H. Raynor, Melanie Bonner, Holly Schweitzer, Karen Carter, Bebe Guill, and Henry S. Friedman. “Development of the duke cancer cognitions inventory-brain tumor version (DCCI-BT).” In Neuro Oncology, 8:476–476. DUKE UNIV PRESS, 2006.

Scholars@Duke

Aapro, M. S., D. A. Cameron, R. Pettengell, J. Bohlius, J. Crawford, M. Ellis, N. Kearney, et al. “EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours..” Eur J Cancer 42, no. 15 (October 2006): 2433–53. https://doi.org/10.1016/j.ejca.2006.05.002.

PMID
16750358
Full Text

Li, Guojun, Xiaodong Zhai, Zhengdong Zhang, Robert M. Chamberlain, Margaret R. Spitz, and Qingyi Wei. “MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis..” Carcinogenesis 27, no. 10 (October 2006): 2028–33. https://doi.org/10.1093/carcin/bgl047.

PMID
16675470
Full Text

Hjelmeland, Anita B., Katie Lattimore, Brian Fee, Sarah Wickman, Stephen T. Keir, Mark D. Hjelmeland, David Batt, et al. “The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion.” In Neuro Oncology, 8:412–412. DUKE UNIV PRESS, 2006.

Scholars@Duke

Pages